Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Lentiviral Vectors Market by Type (1st-generation, 2nd-generation, 3rd-generation), By Application (Hospital, Clinic, Research Institution, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Lentiviral Vectors Market by Type (1st-generation, 2nd-generation, 3rd-generation), By Application (Hospital, Clinic, Research Institution, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 368975 4200 Medical Devices & Consumables 377 215 Pages 5 (43)
                                          

Market Overview:


The global lentiviral vectors market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for gene therapy and growing investment in R&D by pharmaceutical companies. Based on type, the global lentiviral vectors market is segmented into 1st-generation, 2nd-generation and 3rd-generation vectors. The 1st-generation vector segment dominates the global lentiviral vectors market and is expected to continue its dominance during the forecast period. This can be attributed to their high efficiency and easy production process as compared to other types of Lentiviral Vectors. Based on application, the hospital segment dominates the global lentiviral vectors market followed by clinic, research institution and others segments respectively. North America dominates the global LentiVector Market with a share of XX% in 2017 followed by Europe with a share of XX%.


Global Lentiviral Vectors Industry Outlook


Product Definition:


Lentiviral vectors are a type of virus that can transfer genetic material into cells. Lentiviral vectors have been used to deliver genes into muscle cells, neurons, and other types of cells. This technology has been used to study the function of genes and to develop new therapies for diseases such as cancer, AIDS, and heart disease.


1st-generation:


1st generation is the first set of viruses to be used in gene therapy. It was developed by French physician and scientist Robert Gallo for the treatment of cancerous cells. The virus can carry genes into human cells, which then integrate themselves into the cell’s genetic material and produce new proteins from their own nucleic acids (DNA or RNA). These new proteins are often more effective than those produced by the original tissue.


2nd-generation:


2nd generation is also known as Generation II. It is a group of lentiviral vectors developed by the insertion of an envelope gene from HIV-1 into the SARS-CoV-2 genome. The 2nd generation has several advantages over 1st generation such as it can infect both T cells and B cells, has higher transgene expression levels, and shows improved immune stimulation in vitro & in vivo activities.


Application Insights:


The hospital application segment led the market in 2017 and is projected to expand at a revenue-based CAGR of XX% over the forecast period. Lentiviral vectors are widely used for gene therapy, cell therapy, and vaccine production owing to their ability to transfect cells and introduce foreign genes into them with high efficiency. The growing adoption of these vectors for clinical applications such as stem cell therapies is expected to drive demand over the coming years.


Clinical trials are an important part of drug development process in any industry; this includes biopharmaceutical companies, academic institutions/research institutes, and government agencies. Clinical research involves several processes including planning & designing studies & experiments, gathering data from patients or participants involved in clinical trials through various methods such as interviews or questionnaires etc., analyzing data collected from patients or participants involved in clinical trials through various methods such as interviews or questionnaires etc.


Regional Analysis:


North America dominated the market in 2017 owing to a rise in R&D investments by public and private entities. Moreover, high prevalence of chronic diseases such as HIV/AIDS has led to an increase in demand for Lentiviral Vectors Therapy (LVT) which is further expected to drive the regional market over the forecast period.


Asia Pacific region is anticipated to witness lucrative growth during the forecast period due to factors such as rising disposable income, improving healthcare infrastructure and growing target population base. Furthermore, increasing government initiatives towards development of novel therapies are projecteded boost regional growth over next eight years. For instance, National Health & Nutrition Examination Survey (NHANES) survey conducted from 2007-2010 showed that approximately 0.5% of children were born with HIV; this number was increasedto 1% among black children living with mothers who were infected during pregnancy or shortly after birth [1].


Growth Factors:


  • Increasing demand for gene therapy and regenerative medicine
  • Rising prevalence of chronic diseases such as cancer, HIV/AIDS, and heart diseases
  • Growing number of collaborations and partnerships between biotechnology companies and research institutes for development of novel lentiviral vectors
  • Technological advancements in the field of lentiviral vectors production
  • Increasing investment by private equity firms in the biotech sector

Scope Of The Report

Report Attributes

Report Details

Report Title

Lentiviral Vectors Market Research Report

By Type

1st-generation, 2nd-generation, 3rd-generation

By Application

Hospital, Clinic, Research Institution, Others

By Companies

Thermo Fisher Scientific Sirion-Biotech GmbH, Vigene Biosciences, OriGene Technologies, SignaGen Laboratories, Sino Biological, Takara Bio, Cell Biolabs, GenTarget, GENEMEDI, Bluebird Bio

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

215

Number of Tables & Figures

151

Customization Available

Yes, the report can be customized as per your need.


Global Lentiviral Vectors Market Report Segments:

The global Lentiviral Vectors market is segmented on the basis of:

Types

1st-generation, 2nd-generation, 3rd-generation

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Clinic, Research Institution, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Thermo Fisher Scientific Sirion-Biotech GmbH
  2. Vigene Biosciences
  3. OriGene Technologies
  4. SignaGen Laboratories
  5. Sino Biological
  6. Takara Bio
  7. Cell Biolabs
  8. GenTarget
  9. GENEMEDI
  10. Bluebird Bio

Global Lentiviral Vectors Market Overview


Highlights of The Lentiviral Vectors Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. 1st-generation
    2. 2nd-generation
    3. 3rd-generation
  1. By Application:

    1. Hospital
    2. Clinic
    3. Research Institution
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Lentiviral Vectors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Lentiviral Vectors Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Lentiviral vectors are a type of virus that can be used to deliver genes or other treatments into cells. Lentiviral vectors are small, circular pieces of DNA that can travel through the bloodstream and enter cells. Once inside the cell, the lentivirus can release its cargo, which could include genes or other treatments.

Some of the key players operating in the lentiviral vectors market are Thermo Fisher Scientific Sirion-Biotech GmbH, Vigene Biosciences, OriGene Technologies, SignaGen Laboratories, Sino Biological, Takara Bio, Cell Biolabs, GenTarget, GENEMEDI, Bluebird Bio.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lentiviral Vectors Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Lentiviral Vectors Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Lentiviral Vectors Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Lentiviral Vectors Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Lentiviral Vectors Market Size & Forecast, 2020-2028       4.5.1 Lentiviral Vectors Market Size and Y-o-Y Growth       4.5.2 Lentiviral Vectors Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 1st-generation
      5.2.2 2nd-generation
      5.2.3 3rd-generation
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Clinic
      6.2.3 Research Institution
      6.2.4 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Lentiviral Vectors Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Lentiviral Vectors Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 1st-generation
      9.6.2 2nd-generation
      9.6.3 3rd-generation
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Clinic
      9.10.3 Research Institution
      9.10.4 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 1st-generation
      10.6.2 2nd-generation
      10.6.3 3rd-generation
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Clinic
      10.10.3 Research Institution
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 1st-generation
      11.6.2 2nd-generation
      11.6.3 3rd-generation
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Clinic
      11.10.3 Research Institution
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 1st-generation
      12.6.2 2nd-generation
      12.6.3 3rd-generation
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Clinic
      12.10.3 Research Institution
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 1st-generation
      13.6.2 2nd-generation
      13.6.3 3rd-generation
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Clinic
      13.10.3 Research Institution
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Lentiviral Vectors Market: Competitive Dashboard
   14.2 Global Lentiviral Vectors Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Thermo Fisher Scientific Sirion-Biotech GmbH
      14.3.2 Vigene Biosciences
      14.3.3 OriGene Technologies
      14.3.4 SignaGen Laboratories
      14.3.5 Sino Biological
      14.3.6 Takara Bio
      14.3.7 Cell Biolabs
      14.3.8 GenTarget
      14.3.9 GENEMEDI
      14.3.10 Bluebird Bio

Our Trusted Clients

Contact Us